Skip to main content
Clinical Trials/CTRI/2021/08/035508
CTRI/2021/08/035508Not yet recruitingPhase 2

"CLINICAL EVALUATION OF THE EFFICACY OF ‘PANCHTIKTA GHRITA GUGGUL’, ‘KHADIRARISHTA’ AND ‘EDGAJADI LEPA’ IN DADRU [TAENIA CORPORIS]"

Patanjali Ayurveda College1 site in 1 country60 target enrollmentStarted: October 8, 2021Last updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Subject Parameter - Grading will be done considering signs and symptoms of dadru- Kandu, Raga,Pidika, Utsannamandal

Study Overview

Brief Summary

In this trial, we are selecting patient of Dadru (Taenia corporis) in which we will do intervention in single group. We will intervene oral and local administration of ayurvedic drugs (Panchatikta Ghrita Guggulu, Khadirarishta, Edgajadi Lepa). Assessment will be done on basis of subjective & objective parameters.

Dose of medicine-

Panchatikta Ghrita Guggulu 2 tablets twice daily with luke warm water.

Khadirarishta 20 ml with equal amount of water twice daily.

Edgajadi Lepa  local application.

Route of administration- Panchatikta ghrita guggulu and Khadirarista orally, Edgajadi lepa local application.

Follow-up- The follow up will be done after 15 days and 1 month during the trial of 1 month to observe the effects of treatment or any adverse effects on patient.

Study Design

Study Type
Interventional
Allocation
Adaptive randomization, such as minimization
Masking
Open Label

Eligibility Criteria

Ages
16.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • a) Patient with signs and symptoms of Dadru and taenia corporis were included in the study.
  • b) Age group above 16 to 60 years randomly included for study.
  • c) Patients of both sex included for the study.
  • d) Patients having history of less than two years of onset of disease.
  • e) Both fresh and treated cases would be taken for the study.

Exclusion Criteria

  • a) Patients under long standing medication.
  • b) Pregnant women and lactating women.
  • c) Chronicity more than 2 years.
  • d) Age group below 16 years and above 60 years.
  • e) Patient suffering from uncontrolled DM.

Outcomes

Primary Outcomes

Subject Parameter - Grading will be done considering signs and symptoms of dadru- Kandu, Raga,Pidika, Utsannamandal

Time Frame: Before intervention of the drugs for one month with Panchatikta Ghrita Guggulu and Khadirarishta orally,Edgajadi Lepa locally.

Objective Parameter-

Time Frame: Before intervention of the drugs for one month with Panchatikta Ghrita Guggulu and Khadirarishta orally,Edgajadi Lepa locally.

Size of Mandal is assessed

Time Frame: Before intervention of the drugs for one month with Panchatikta Ghrita Guggulu and Khadirarishta orally,Edgajadi Lepa locally.

Secondary Outcomes

  • Subject Parameter - Grading will be done considering signs and symptoms of dadru- Kandu, Raga,Pidika, Utsannamandal(Objective Parameter-)

Investigators

Sponsor
Patanjali Ayurveda College
Sponsor Class
Research institution and hospital

Study Sites (1)

Loading locations...

Similar Trials